Why the study?
Do presensitization and circulating antibodies play a role in acute cardiac-allograft rejection in patients receiving cardiac transplants?
Do presensitization and circulating antibodies play a role in acute cardiac-allograft rejection in patients receiving cardiac transplants?
Presensitization and early antibody response may play a role in virulent acute rejection of cardiac allografts.
Answers are grounded in this paper and cite their sources.
Presensitization may contribute to early cardiac allograft rejection; hypothesis-generating and requires prospective validation before guiding practice.
Three of four patients receiving cardiac allografts died of acute rejection at seven, seven and 18 days. Serologic studies were performed with the use of kidney cells cultured from the donor in an attempt to assess the role of presensitization and circulating antibody in this fulminating variety of rejection. Evidence of presensitization to antigens present on donor kidney cells was found in one patient, and antibody was eluted from the rejected hearts in each case. Presensitization and an early antibody response may have some role in virulent acute rejection.
No takes yet. Share an insight, caveat, or question.
Williams et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: